Full-Time

Manager Quality Assurance

Posted on 3/4/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Compensation Overview

$96.3k - $160.5k/yr

+ Bonus + Share-based Long Term Incentive Program

Mid, Senior

No H1B Sponsorship

Groton, CT, USA

Hybrid work arrangement.

Category
QA & Testing
Quality Assurance
Required Skills
Risk Management
Requirements
  • BA/BS with at least 4 years of experience or MBA/MS with at least 2 years of experience or PhD/JD with any years of experience or associate's degree with at least 8 years of experience or high School Diploma (or Equivalent) with at least 10 years of relevant experience
  • Substantial experience in pharmaceutical manufacturing and quality control
  • Familiarity with Current Good Manufacturing Practices (cGMP) and handling compliance issues arising from cGMP deviations or product defects
  • Knowledge of regulations related to vendor management programs and other industry quality systems
  • Strong critical thinking skills and a proactive approach
  • Ability to collaborate effectively, manage relationships, and communicate well both in writing and verbally
  • Advanced computer skills in MS Office applications and a good understanding of enterprise systems such as EMD, Quality Tracking System Trackwise, eQMS and Documentum platforms
Responsibilities
  • Provide Quality support and oversight for early phase and Co-Development programs within PSSM
  • Provide Quality oversight and expertise related to project work that may involve external vendor facilities or at PGS sites on behalf of PSSM for API and drug product
  • As needed, interface with the PSOQ Vendor QA group to ensure that work placed at external vendors is manufactured to the high GMP expectations of Pfizer
  • Depending on project demands, partner with a QA Associate to provide an interface between the project team and other functions within Quality Assurance and QSEO
  • Interface with colleagues providing QA oversight and support for internal API and DP manufacturing operations to ensure timely release of materials
  • As project work demands, lead investigations related to product/facility deviations and investigations including root cause analysis, and Pfizer Human Performance assessments
  • Use risk-management tools to assess quality issues occurring during manufacturing/testing activities
  • Work with PSSM, Global Clinical Supply, PGS and external manufacturing vendors to define and implement CAPA activities for investigations and follow-up trend analysis
  • Support PSSM and PGS colleagues in the development of procedures which increase efficiency and maintain high quality standards
  • Provide support to internal audits (e.g. RQA) & regulatory inspections (e.g. FDA, MHRA) when required
  • Leads and/or participates on limited duration teams, continuous improvement initiatives and special projects for PSOQ and PSSM
  • Make decisions to resolve moderately complex problems, develop new options guided by policies, and operate independently in ambiguous situations
  • Utilize judgment and experience to potentially become a resource for others, and evaluate clinical and commercial drug batches to ensure adherence to specifications
Desired Qualifications
  • Experience in Quality Systems in pharmaceutical, medical device, or combination product industry
  • Knowledge or exposure to data science
  • Strong leadership and team management skills
  • Ability to work under pressure and meet tight deadlines
  • Ability to influence and negotiate with stakeholders
  • Experience in conducting internal audits and supporting regulatory inspections
  • Aseptic experience

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, oncology treatments, and other specialized medicines, with a significant role in developing a vaccine for COVID-19 in partnership with BioNTech. What sets Pfizer apart from its competitors is its strong commitment to public health, demonstrated by efforts to provide vaccines to underserved populations and a continuous expansion of its product portfolio through new approvals. The goal of Pfizer is to improve health outcomes worldwide by delivering effective healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE